Medicines
2000-07-312000-08-112000-08-042000-07-262000-07-242000-08-012000-08-25TSO (The Stationery Office), St Crispins, Duke Street, Norwich, NR3 1PD, 01603 622211,
customer.services@tso.co.uk55953UN007UN007
PI 06464/0896 | Waymade plc | Amaryl 4 mg Tablets | Glimepiride 4.000 mg | Diabetes Mellitus. Prescription Only Medicine | 1st August 2000 |
PI 06464/0907 | Waymade plc | Loceryl Nail Lacquer | Amorolfine Hydrochloride 55.750 mg/ml | Onychomycoses caused by dermatophytes, yeasts and moulds. Prescription Only Medicine | 24th July 2000 |
PI 06464/0909 | Waymade plc | Climagest 2 mg Tablets | Estradiol Valerate 2.000 mg Estradiol Valerate 2.000 mg Norethisterone 1.000 mg | The treatment of menopausal symptoms. Prescription Only Medicine | 26th July 2000 |
PI 06464/0919 | Waymade plc | Amlodipine 10 mg Tablets | Amlodipine Besylate 13.889 mg | Hypertension; angina pectoris. Prescription Only Medicine | 4th August 2000 |
PI 06464/0942 | Waymade plc | Fosamax 10 mg Tablets | Alendronate Sodium 13.050 mg | Osteoporosis. Prescription Only Medicine | 11th August 2000 |
PI 06464/0958 | Waymade plc | Singulair Paediatric 5 mg Chewable Tablets | Montelukast Sodium 5.200 mg | Treatment of asthma. Prescription Only Medicine | 24th July 2000 |
08336/0076 | Asta Medica Limited | Azelastine Tablets 4 mg | Azelastine Hydrochloride 4.400 mg | Symptomatic treatment of itch associated with chronic idiopathic urticaria for up to 21 days, hereafter the need for treatment should be reviewed. Prescription Only Medicine | 1st August 2000 |
08557/0044 | Shire Pharmaceuticals Limited | Colazide | Balsalazide Disodium 750.000 mg | Treatment of mild-to-moderate active ulcerative colitis and maintenance of remission. Prescription Only Medicine | 1st August 2000 |
08801/0047 | BPL, Bio Products Laboratory | Human Anti-D Immunoglobulin S/D | Human Anti-D Immunoglobulin 250.000 iu | Prevention of Rh(D) Immunisation in Rh(D) Negative Women: (i) During pregnancy, or after delivery of a Rh(D) positive baby, irrespective of the ABO groups of mother and baby, i.e. at 28 and 34 weeks of pregnancy in Rh(D) negative women and repeated within 72 hours of delivery if the baby is Rh(D) positive. (ii) Soon after an abortion/threatened abortion, or diagnosis of ectopic pregnancy or hydatidiform mole. (iii) Soon after anti-partum haemorrhage (APH), amniocentesis, chorionic biopsy or obstetric manipulative procedure e.g. version, or abdominal trauma which may cause transplacental haemorrhage (TPH). (iv) After transfusion of Rh(D) incompatible blood or blood products. Treatment of Rh(D) negative patients after incompatible transfusions of Rh(D) positive blood or erythrocyte concentrate. Prescription Only Medicine | 31st July 2000 |
08801/0048 | BPL, Bio Products Laboratory | Human Anti-D Immunoglobulin S/D | Human Anti-D Immunoglobulin 500.000 iu | (See PL 08801/0047) Prescription Only Medicine | 31st July 2000 |